Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-07-11

FDA Approved: VASOPRESSIN IN 0.9% SODIUM CHLORIDE — Original Application (Long Grove Pharmaceuticals, LLC)

View source ↗

Summary

FDA approved VASOPRESSIN IN 0.9% SODIUM CHLORIDE from Long Grove Pharmaceuticals as an original NDA for vasopressin injection to be used as a vasopressor to rai…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • VASOPRESSIN IN 0.9% SODIUM CHLORIDE (vasopressin)

Snippet

ORIG AP for VASOPRESSIN IN 0.9% SODIUM CHLORIDE (VASOPRESSIN)